Literature DB >> 9009326

Selection of Opa+ Neisseria gonorrhoeae by limited availability of normal human serum.

M P Bos1, D Hogan, R J Belland.   

Abstract

Experimental infections of human male volunteers with Neisseria gonorrhoeae have provided valuable insights into the early stages of gonorrheal disease. Bacterial variants expressing outer membrane opacity (Opa) proteins appear to be selected from the inoculum during a period in which total recoverable numbers of bacteria decrease rapidly. This apparent survival advantage occurs simultaneously with the onset of an inflammatory response, characterized by local production of interleukin 6 (IL-6) and IL-8 and the appearance of leukocytes in urine. Since the inflammatory response may also result in the presence of serum factors on the mucosal surface, we investigated the possibility that killing in normal human serum (NHS) leads to the selection of Opa+ variants. We therefore studied killing of separate populations and mixtures of Opa- and Opa+ N. gonorrhoeae MS11mk in NHS. Expression of an Opa protein conferred a survival advantage upon the organism; i.e., the Opa+ variants were more serum resistant than their isogenic Opa- counterparts, resulting in a selection for Opa+ phenotypes when a mixture of Opa+ and Opa- gonococci (GC) was exposed to submaximal doses of NHS. This selection was observed in three different lipooligosaccharide (LOS) backgrounds, indicating that it was not due to a difference in LOS expression between Opa- and Opa+ phenotypes. Incubation in NHS of sialylated GC resulted in a similar selection for Opa+ variants. The presence of normal human urine during the serum killing assay had no effect on the selection phenomenon but drastically depleted NHS of bactericidal activity, which was found to be at least partly due to complement inhibition. The results suggest that serum killing may contribute to the transition from Opa- to Opa+ phenotypes during the early stages of infection of the male urethra.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009326      PMCID: PMC176109          DOI: 10.1128/iai.65.2.645-650.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity.

Authors:  H Smith; N J Parsons; J A Cole
Journal:  Microb Pathog       Date:  1995-12       Impact factor: 3.738

2.  Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.

Authors:  K A Joiner; R Scales; K A Warren; M M Frank; P A Rice
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

4.  Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.

Authors:  K A Joiner; K A Warren; E J Brown; J Swanson; M M Frank
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

5.  Gonococci in urethral exudates possess a virulence factor lost on subculture.

Authors:  M E Ward; P J Watt; A A Glynn
Journal:  Nature       Date:  1970-07-25       Impact factor: 49.962

6.  The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies.

Authors:  R J Price; B Boettcher
Journal:  Fertil Steril       Date:  1979-07       Impact factor: 7.329

7.  Relation of protein I and colony opacity to serum killing of Neisseria gonorrhoeae.

Authors:  J F James; E Zurlinden; C J Lammel; G F Brooks
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

8.  Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae.

Authors:  H Schneider; J M Griffiss; R E Mandrell; G A Jarvis
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Bactericidal properties of urine for Neisseria gonorrhoeae.

Authors:  R C Noble; M C Parekh
Journal:  Sex Transm Dis       Date:  1987 Oct-Dec       Impact factor: 2.830

10.  Expression of outer membrane protein II by gonococci in experimental gonorrhea.

Authors:  J Swanson; O Barrera; J Sola; J Boslego
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more
  12 in total

1.  In vivo selection for Neisseria gonorrhoeae opacity protein expression in the absence of human carcinoembryonic antigen cell adhesion molecules.

Authors:  Amy N Simms; Ann E Jerse
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Phenotypic and genotypic analyses of Neisseria gonorrhoeae isolates that express frequently recovered PorB PIA variable region types suggest that certain P1a porin sequences confer a selective advantage for urogenital tract infection.

Authors:  Lotisha E Garvin; Margaret C Bash; Christine Keys; Douglas M Warner; Sanjay Ram; William M Shafer; Ann E Jerse
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

Review 3.  Focusing homologous recombination: pilin antigenic variation in the pathogenic Neisseria.

Authors:  Laty A Cahoon; H Steven Seifert
Journal:  Mol Microbiol       Date:  2011-08-04       Impact factor: 3.501

4.  Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR.

Authors:  C W M Geraats-Peters; M Brouwers; P M Schneeberger; A G M van der Zanden; S M Bruisten; G Weers-Pothoff; C H E Boel; A J C van den Brule; H G Harmsen; M H A Hermans
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice.

Authors:  A E Jerse
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Differential recognition of members of the carcinoembryonic antigen family by Opa variants of Neisseria gonorrhoeae.

Authors:  M P Bos; F Grunert; R J Belland
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

8.  Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control.

Authors:  Jessica G Cole; Nanette B Fulcher; Ann E Jerse
Journal:  Infect Immun       Date:  2010-01-25       Impact factor: 3.441

9.  Contrasting within- and between-host immune selection shapes Neisseria Opa repertoires.

Authors:  Eleanor R Watkins; Yonatan H Grad; Sunetra Gupta; Caroline O Buckee
Journal:  Sci Rep       Date:  2014-10-09       Impact factor: 4.379

10.  Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.

Authors:  Jessica G Cole; Ann E Jerse
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.